These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34380471)

  • 21. LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.
    Lai XJ; Cheng HF
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):322-328. PubMed ID: 29424889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA CCAT1 promotes cell proliferation and metastasis in human medulloblastoma via MAPK pathway.
    Gao R; Zhang R; Zhang C; Zhao L; Zhang Y
    Tumori; 2018; 104(1):43-50. PubMed ID: 28777430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
    Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
    Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of long noncoding RNA CCAT1 inhibits cell growth, invasion and peritoneal metastasis via downregulation of Bmi-1 in gastric cancer.
    Li N; Jiang K; Fang LP; Yao LL; Yu Z
    Neoplasma; 2018 Sep; 65(5):736-744. PubMed ID: 29940756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR-219-1.
    Li Y; Zhu G; Ma Y; Qu H
    J Cell Biochem; 2019 Dec; 120(12):19457-19468. PubMed ID: 31478245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery.
    Zhao Y; Lin D; Wu F; Guo L; He G; Ouyang L; Song X; Huang W; Li X
    Int J Mol Sci; 2014 Sep; 15(10):17565-76. PubMed ID: 25268623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
    Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
    Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy.
    Guo F; Fu Q; Zhou K; Jin C; Wu W; Ji X; Yan Q; Yang Q; Wu D; Li A; Yang G
    J Nanobiotechnology; 2020 Mar; 18(1):48. PubMed ID: 32183823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
    Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
    Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells.
    Abedi F; Davaran S; Hekmati M; Akbarzadeh A; Baradaran B; Moghaddam SV
    J Nanobiotechnology; 2021 Jan; 19(1):18. PubMed ID: 33422062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traditional Chinese Medicine Curcumin Sensitizes Human Colon Cancer to Radiation by Altering the Expression of DNA Repair-related Genes.
    Yang G; Qiu J; Wang D; Tao Y; Song Y; Wang H; Tang J; Wang X; Sun YU; Yang Z; Hoffman RM
    Anticancer Res; 2018 Jan; 38(1):131-136. PubMed ID: 29277765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b.
    Cui B; Li B; Liu Q; Cui Y
    J Cell Biochem; 2017 Dec; 118(12):4548-4557. PubMed ID: 28475287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.
    Gou M; Men K; Shi H; Xiang M; Zhang J; Song J; Long J; Wan Y; Luo F; Zhao X; Qian Z
    Nanoscale; 2011 Apr; 3(4):1558-67. PubMed ID: 21283869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
    Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells.
    Chen J; Zhang K; Song H; Wang R; Chu X; Chen L
    Oncotarget; 2016 Sep; 7(38):62474-62489. PubMed ID: 27566568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis.
    Sun M; Shen Z
    Med Sci Monit; 2020 Feb; 26():e920020. PubMed ID: 32009633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.